Keywords: GlaxoSmithKline, Neptunus, Joint venture, Vaccines, China, Arecor

GlaxoSmithKline takes full control of Neptunus JV; links with Arecor on vaccines

Article | 15 June 2011

Print This

In one of two pieces of vaccine-related news yesterday, GlaxoSmithKline (LSE: GSK) said it is acquiring the remaining 51% equity interest ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in